# Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

> **NCT00634491** · PHASE2 · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 240 (actual)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** sodium bicarbonate
- **DRUG:** Acetazolamide
- **DRUG:** normal salin

## Key facts

- **NCT ID:** NCT00634491
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2008-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00634491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00634491, "Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00634491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*